Recent TAU study demonstrates how a crucial but underexplored process of DNA transfer between bacteria affects its defense ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste. This is the reality of CRISPR, a ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

In a groundbreaking study, scientists have discovered a way to manipulate the very fabric of life by using light to reshape ...

Professor Kevin J. Zwezdaryk and Chandler H. Monk discuss CRISPR and diagnostics, focusing on the development of a portable ...

In summary, CRISPR offers hope in the fight against aging-related diseases by targeting the underlying genetic causes. It has already shown promise in conditions like Alzheimer’s, heart disease, and ...

According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 ...